JUMP REPORT
| Avg Daily Volume: 7,204,636 Market Cap: 46.03B Sector: Consumer Goods Short Interest: 27.86 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.42/share REV: 6,330/M
___________________________________________________________
LAST QTR: EPS: -.36/share ACTUAL: -1.12/share (MISS)
____________________________________________________________
NEXT QTR: EPS: .32/share REV: 6,790/M
______________________________________________________
FULL YR: EPS: -3.57/share REV: 24,540/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 30% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -14.84, -4.86, -4.78
EXPECTED JUMP MOVE: 8-12%
Links To Latest News and Headlines
Also, how to pick preferred stocks, opportunities in a bear market, preparing for a recession and reverse mortgages.
Tesla’s production forecast, if achieved, would put the EV maker on track to meet Elon Musk’s goal for production in the coming quarter and put the automaker close to the scale of German luxury automaker BMW by end 2023. Musk and Tesla have a record of pointing to stretch targets the company has not always met. In April, for instance, Musk had said Tesla could hit 60% growth in deliveries.
In this video, I will be talking about Rivian (NASDAQ: RIVN) and whether it has the potential to 10x, as well as looking at some recent comments by analysts following the company. I’ll compare it to the likes of Tesla and Ford to better understand what the company could realistically achieve over time.
Yahoo Finance’s Ines Ferre joins the Live show to break down how stocks are moving in early trading.
The Dow Jones Industrial Average dropped Friday on hot inflation data. Tesla stock fell ahead of the company’s AI Day.
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
ANALYSIS:
StockJumpers preliminary study reveals a negative market reaction to the target release. We are reviewing additional data – but it looks like a miss on some of the metrics. All eyes are on deliveries and future clues about any weakness in sales and deliveries. They may beat on the bottom line – but not going forward..
We are biased SHORT on the event.
___________________
OUR TRADE PLAN:
ENTRY: SELL – end of day
STOP LOSS: NA
INITIAL PROFIT TARGET: 7%
___________________
TRADE ASSIST: YES
POST RELEASE ACTION:
[/mepr-show
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.